| Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium VV Glinsky, GV Glinsky, OV Glinskii, VH Huxley, JR Turk, VV Mossine, ... Cancer research 63 (13), 3805-3811, 2003 | 303 | 2003 |
| The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium VV Glinsky, GV Glinsky, K Rittenhouse-Olson, ME Huflejt, OV Glinskii, ... Cancer research 61 (12), 4851-4857, 2001 | 302 | 2001 |
| Modified citrus pectin anti-metastatic properties: one bullet, multiple targets VV Glinsky, A Raz Carbohydrate research 344 (14), 1788-1791, 2009 | 282 | 2009 |
| MDA-MB-435 human breast carcinoma cell homo-and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions SK Khaldoyanidi, VV Glinsky, L Sikora, AB Glinskii, VV Mossine, TP Quinn, ... Journal of Biological Chemistry 278 (6), 4127-4134, 2003 | 210 | 2003 |
| Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs OV Glinskii, VH Huxley, GV Glinsky, KJ Pienta, A Raz, VV Glinsky Neoplasia 7 (5), 522-527, 2005 | 203 | 2005 |
| Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast … VV Glinsky, ME Huflejt, GV Glinsky, SL Deutscher, TP Quinn Cancer research 60 (10), 2584-2588, 2000 | 197 | 2000 |
| Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion J Zou, VV Glinsky, LA Landon, L Matthews, SL Deutscher Carcinogenesis 26 (2), 309-318, 2005 | 182 | 2005 |
| Resistance to apoptosis in human cells conferred by telomerase function and telomere stability SE Holt, VV Glinsky, AB Ivanova, GV Glinsky Molecular carcinogenesis 25 (4), 241-248, 1999 | 168 | 1999 |
| Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms GV Glinsky, VV Glinsky, AB Ivanova, CJ Hueser Cancer letters 115 (2), 185-193, 1997 | 166 | 1997 |
| Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death GV Glinsky, VV Glinsky Cancer letters 101 (1), 43-51, 1996 | 129 | 1996 |
| Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library NG Karasseva, VV Glinsky, NX Chen, R Komatireddy, TP Quinn Journal of protein chemistry 21 (4), 287-296, 2002 | 123 | 2002 |
| Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia KD Johnson, OV Glinskii, VV Mossine, JR Turk, TP Mawhinney, ... Neoplasia 9 (8), 662-670, 2007 | 121 | 2007 |
| Inhibition of Spontaneous Breast Cancer Metastasis by Anti—Thomsen-Friedenreich Antigen Monoclonal Antibody JAA-F11 J Heimburg, J Yan, S Morey, OV Glinskii, VH Huxley, L Wild, R Klick, ... Neoplasia 8 (11), 939-948, 2006 | 106 | 2006 |
| Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines GV Glinsky, JE Price, VV Glinsky, VV Mossine, G Kiriakova, JB Metcalf Cancer research 56 (23), 5319-5324, 1996 | 106 | 1996 |
| Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine OV Glinskii, S Sud, VV Mossine, TP Mawhinney, DC Anthony, GV Glinsky, ... Neoplasia 14 (1), 65-73, 2012 | 77 | 2012 |
| Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries EN Peletskaya, VV Glinsky, GV Glinsky, SL Deutscher, TP Quinn Journal of molecular biology 270 (3), 374-384, 1997 | 76 | 1997 |
| Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo VV Glinsky, G Kiriakova, OV Glinskii, VV Mossine, TP Mawhinney, JR Turk, ... Neoplasia 11 (9), 901-909, 2009 | 71 | 2009 |
| Evidence of porcine and human endothelium activation by cancer‐associated carbohydrates expressed on glycoproteins and tumour cells OV Glinskii, JR Turk, KJ Pienta, VH Huxley, VV Glinsky The Journal of physiology 554 (1), 89-99, 2004 | 58 | 2004 |
| Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy A Almogren, J Abdullah, K Ghapure, K Ferguson, VV Glinsky, ... Front Biosci (Schol Ed) 4, 840-863, 2012 | 48 | 2012 |
| Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen J Heimburg-Molinaro, A Almogren, S Morey, OV Glinskii, R Roy, ... Neoplasia 11 (8), 780-792, 2009 | 46 | 2009 |
Gennadi GlinskyResearch Scientist, Institute of Engineering in Medicine, University of California, San DiegoVerified email at ucsd.edu
